Latest News
Burberry profits and cashflow outstrip forecasts
Burberry presented a smart first set of full year results under new chief executive Marco Gobbetti, pinning on a £150m buyback buttonhole as well as outstripping City forecasts despite a slight wrinkle in revenues.
FTSE 250 movers: Homeserve upgrade warms investors; Crest Nicholson disappoints
Homeserve led the FTSE 250 risers on Wednesday and helped lift the index into positive territory. The stock was boosted after UBS issued an upgrade to 'buy' from 'neutral'.
US industrial production falls short of forecasts in March
US industrial production fell short of forecasts last month despite a sharp jump in the output of business equipment.
Tory policy changes caused 'worrying' collapse in clean energy investment - MPs
UK government policy changes have contributed to a “dramatic and worrying” collapse in clean energy investment since 2015, a committee of MPs said on Wednesday.
Households to cough extra £1.5bn after tweak in green subsidy backfires
UK energy users will be forced to pay an extra £1. 5bn for their green energy over the next fifteen years due to a tweak of the government’s policy on green energy subsidies, the National Audit Office has warned.
Carillion directors, auditors lambasted in parliament report
Directors and auditors of failed UK government outsourcer Carillion were lambasted in a scathing parliamentary report on Wednesday with all sides accused of complicity in the company's demise last January.
US housing starts peak in April, economists say
A key gauge of housing market activity in the US turned down last month, although the details of the report were somewhat stronger, according to economists.
Goldman Sachs and Citi downgrade Evraz
Following the recent strong share price performance from Evraz, analysts at Goldman Sachs and Citi both saw fit to downgrade their ratings for the Russian steelmaker on Wednesday.
Zoetis to buy veterinary diagnostics group Abaxis for $2bn
US animal health company Zoetis Inc has agreed to buy veterinary diagnostics group Abaxis for $83 per share in cash, or around $2bn.
Thalassa buys back another 40,000 shares
Thalassa announced on Wednesday that, on 15 May, it purchased 40,000 of its shares at a price of 84p per share.
FastForward authorised as a closed-ended investment scheme in Guernsey
FastForward Innovations has been authorised as a closed-ended investment scheme by the Guernsey Financial Services Commission, it announced on Wednesday.
Augean makes moves to shutter Colt division
Specialist waste management company Augean updated the marker on its ongoing programme to optimise business units and turn around those that were underperforming on Wednesday.
Best of the Best ends year in line as it expands luxury prize catalogue
Luxury prize competition organiser Best of the Best updated the market on its trading on Wednesday, saying the 12 months ended 30 April had been “encouraging”, with profit before tax “comfortably” in line with management's expectations.
Mortgage Advice Bureau adds advisers and grows business, investors told
Investors in Mortgage Advice Bureau were told how adviser numbers had continued to grow on Wednesday, increasing to 1,116 advisers as at 11 May, as they gathered for the company’s annual general meeting.
Volex to buy cable harness manufacturer Silotec in EUR 18m deal
Cable assemblies supplier Volex announced the proposed acquisition of the business and assets of Silcotec Europe, a manufacturer and seller of cable harnesses, for a total consideration of up to €18. 1m on Wednesday.
Idorsia begins MODIFY study in patients with Fabry disease
Idorsia announced on Wednesday that the first patient has been enrolled in a registration study to investigate the effect of lucerastat as an oral monotherapy for the treatment of adult patients with genetically confirmed Fabry disease, irrespective of their genetic mutation type.
North Korea threatens to call off US summit over nuclear demands
North Korea said it will not engage in economic trade with the US in exchange for its denuclearization and threatened to cancel the upcoming summit between leader Kim Jong-Un and US president Donald Trump.
Optibiotix inks agreement with Indian drug maker
AIM-quoted life sciences business OptiBiotix has entered into a five-year agreement with Akums Drugs and Pharmaceuticals to exclusively manufacture and supply products containing its cholesterol and blood pressure reducing product, LPLDL, to the Indian market.
Wednesday broker round-up
Centrica: Morgan Stanley downgrades to underweight with a target price of 115p.
Seeing Machines extends Guardian agreement with Australian firm
AIM-quoted computer vision technologies firm Seeing Machines has significantly extended an agreement with Western Australia based distributor Connect Source to deliver a further 2,500 units of the company's fleet product, Guardian.